BetterScholar BetterScholar
9
Role
Title
Level Year L/R
🐢 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
200 auth. C. Roux, A. Astrup, K. Fujioka, F. Greenway, D. Lau, L. Gaal, R. Ortíz, John P H Wilding, T. V. Skjøth, L. S. Manning, X. Pi-Sunyer, A. Hamann, Alain Barakat, M. Blüher, T. Linn, ... A. Mölle, A. Segner, Petra Stübler, Regina Tosch-Sisting, F. Pacini, F. Santini, G. Marchesini, C. Rotella, C. Invitti, R. Vettor, S. Buscemi, P. M. Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, R. Carraro, E. Bobillo, C. Cuesta, C. Farsang, A. Császár, B. Zahorska‐Markiewicz, D. Pupek-Musialik, E. Franek, L. Ostrowska, M. Olszanecka-Glinianowicz, N. Lalic, D. Micić, B. Ludvik, B. Paulweber, R. Prager, A. Scheen, A. Astrup, K. Hermansen, S. Madsbad, A. Rissanen, S. Nieminen, M. Savolainen, M. Krempf, M. Romon, M. Laville, M. Marre, Reginald Mira, F. Finucane, A. Veenendaal, F. V. Berkum, Solrun Johannsson-Vidarsdóttir, V. V. D. Walle, E. Meesters, J. Hjelmesæth, T. Klemsdal, B. Kulseng, B. Bach-Kliegel, K. Laederach, L. Villiger, A. Golay, S. Bilz, T. Sathyapalan, S. Bain, Sudesh Kumar, C. Roux, M. Lean, B. McGowan, T. Rehman, J. Wilding, G. Wittert, I. Caterson, Joeseph Proietto, J. Prins, Bruno Geloneze Neto, J. Gross, A. Chacra, A. Halpern, Henrique de Almeida Suplicy, F. Chow, H. Thacker, M. Chadha, Hemaraj Chandalia, A. Unnikrishnan, S. Kalra, N. Deshpande, M. Shunmugavelu, V. Deshmukh, M. Maislos, Gabriella Segal Lieberman, Ilan Shimon, N. Stern, D. Nabriski, E. Karnieli, N. Shehadeh, G. González-Gálvez, M. R. Arechavaleta-Granell, R. Ortíz, G. M. Franco, I. Gurieva, Lyudmila Suplotova, Ekaterina Troshina, L. Ruyatkina, E. A. Voychik, S. Martsevich, M. A. Startseva, M. Seeber, Aysha Badat, G. Ellis, Y. Altuntas, S. Guler, Ender Ulgen, T. Delibaşı, T. Chetty, Randy Hart, Jeannette Janzen, Isabelle Labonté, D. Lau, J. Liutkus, Dennis O'Keefe, R. Padwal, T. Ransom, R. Tytus, S. Weisnagel, Jay C. Adler, K. Aqua, S. Aronoff, Gary W. Bedel, T. Blevins, Joseph Blumenau, A. Brockmyre, R. Call, Rafael Cañadas, L. Chaykin, Kenneth Cohen, Jeffrey Keith Conrow, M. Davis, H. J. Downey, S. Drosman, S. Duckor, H. Farmer, James Farrell, Stephen Fehnel, M. P. Finneran, Raymond L. Forbes, A. Forker, Mark A. Fredrick, Steven A. Geller, Santosh K. Gill, Linda B. Glaser, Susan Greco, F. Greenway, W. Harper, Lee Herman, J. Hoekstra, Richard J. Ingebretsen, R. Ison, R. Jain, R. Kaplan, Steven Richard Kaster, Gregory A Haase, B. Kerzner, Judith Kirstein, W. Koltun, D. Krieger, C. E. Lewis, Robert Madder, R. N. Marple, E. McDermott, Curtis J. Mello, Alan Miller, Julie A. Mullen, John Nardandrea, P. O'Neil, F. Pi‐Sunyer, Ronald M Pucillo, Chanhaeng Rhee, Scott Redrick, A. Pardini, J. Rothman, D. Rubino, G. Sellers, Timothy Smith, W. D. Byars, J. Soufer, A. Sussman, Kyle Patrick, Erich Schramm, M. Cleeff, S. Berg, H. Wyatt, J. Simon
9 2017
9
🐢
🐢 Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
7 auth. Christopher Gallagher, B. Ettinger, M. Gass, R. Kagan, B. McClung, M. McClung, ... J. Simon
6 2002
6
🐢
🐜 Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies.
24 auth. E. Surrey, Hugh S. Taylor, L. Giudice, B. Lessey, M. Abrão, D. Archer, M. Diamond, N. Johnson, N. Watts, J. Gallagher, ... J. Simon, B. Carr, W. Dmowski, N. Leyland, S. Singh, T. Rechberger, S. K. Agarwal, W. Duan, B. Schwefel, James W. Thomas, P. Peloso, J. Ng, A. Soliman, K. Chwalisz
6 2018
6
🐜
🐬 Effects of risedronate on fracture risk in postmenopausal women with osteopenia
E. Siris, J. Simon, I. Barton, M. McClung, A. Grauer
6 2007
6
🐬
🐢 The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
R. Nappi, N. Panay, N. Bruyniks, C. Castelo-Branco, T. D. Villiers, J. Simon
5 2014
5
🐢
🐜 Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group
15 auth. J. Bilezikian, C. Lin, J.P. Brown, A.T. Wang, X. Yin, P. Ebeling, A. Fahrleitner-Pammer, E. Franek, N. Gilchrist, P. Miller, ... J. Simon, I. Valter, C. Zerbini, C. Libanati, A. Chines
4 2019
4
🐜
🐜 Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms
7 auth. G. Constantine, D. Revicki, R. Kagan, J. Simon, S. Graham, B. Bernick, ... S. Mirkin
4 2019
4
🐜
🐜 Denosumab effects on radius BMD, estimated strength, and wrist fractures: 3-year results from the FREEDOM study
14 auth. O. Tørring, J. Simon, C. Recknor, A. Moffet, J. Adachi, E. Franek, E. Lewiecki, C. Mautalen, S. R. Eis, G. Nicholson, ... C. Muschitz, R. Nuti, Andrea T Wang, C. Libanati
1 2012
1
🐜
🦁 Long-Term Safety of Elagolix With Hormonal Add-Back Therapy in Women With Endometriosis-Associated Pain: 24-Month Results [A86]
J. Simon, Jin Hee Kim, James W. Thomas, P. Miller, M. Snabes
0 2022
0
🦁